Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  thiotepa
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 289 for your search:
Start Over
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and under
Sponsor: Other
Protocol IDs: CDR0000066400, MSGCC-9739, NCI-V98-1433, NCT00003398
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 30
Sponsor: Other
Protocol IDs: EUDRACT 2005-002618-40, BfArM-4030755, EC-105/05, DKS 2006.01, DK 2008.17, NCT00749723
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12154, NCT01438112
Phase III Randomized Study of PIXY321 vs GM-CSF for Mobilization of Hematopoietic Progenitors in Women with Metastatic Breast Carcinoma (Summary Last Modified 03/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058
Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: DM95-047, P30CA016672, MDA-DM-95047, NCI-G96-1014, CDR0000065048, NCT00002836
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 60
Sponsor: Other
Protocol IDs: PEGASE03, FRE-FNCLCC-PEGASE03, EU-96032, NCT00002870
Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18-physiologic 60
Sponsor: NCI, Other
Protocol IDs: CDR0000065391, CCCWFU-95496, NCI-G97-1145, NCT00002942
Phase III Study of Two CMFVP (CTX/MTX/5-FU/VCR/PRED) Regimens with or without VATH (VBL/ADR/Thiotepa/FXM) as Adjuvant Chemotherapy for Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI
Protocol IDs: CLB-8082, CALGB-8082
Phase III Adjuvant Therapy with CMFPT vs CMF(P)TH and TsAVbTH, Followed by TMX vs Observation for Resected Premenopausal Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: premenopausal
Sponsor: NCI
Protocol IDs: EST-5181
Phase III Chemotherapy with DAVcH (DBD/ADR/VCR/HAL) vs TsAVbH (Thiotepa/ADR/VBL/HAL) for Disseminated or Recurrent Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-6181
Phase III Intravesical Chemotherapy with Thiotepa vs Mitomycin-C for Superficial Bladder Carcinoma with Residual Tumor
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-10
Phase III Intravesical Thiotepa, with vs without Continued Treatment, in Patients with Resected Superficial Bladder Tumors at Risk of Recurrence
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-11
Phase III BTOC (BCNU/Thiotepa/VCR/CTX) vs VP-16/CACP for Small Cell Carcinoma of the Lung That Has Failed or Relapsed on Primary Chemotherapy
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8215
Phase III Intravesicular Therapy with Thiotepa vs Tice BCG for Completely Resected, Recurrent, or Multiple Non-Invasive Bladder Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SEG-GU-83321, SEG-GU-83-321
Start Over